Differences in survival improvement between known and unknown primary Merkel cell carcinoma in the era of immune checkpoint inhibitors - 03/11/25
Doi : 10.1016/j.jaad.2025.10.029
Zehao Luo, MD a, b, Yuming Sun, PhD a, b, c, Ziyu Guo, PhD a, b, Furong Zeng, PhD a, b, d, ⁎ 
, Guangtong Deng, PhD a, b, ⁎
, Guangtong Deng, PhD a, b, ⁎ a Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China
b Furong Laboratory, Changsha, China
c Department of Plastic and Cosmetic Surgery, Xiangya Hospital, Central South University, Changsha, China
d Department of Oncology, Xiangya Hospital, Central South University, Changsha, China
∗Correspondence to: Furong Zeng, PhD, Department of Oncology, Xiangya hospital, Central South University, 87 Xiangya Road, Changsha, Hunan 410008, ChinaDepartment of OncologyXiangya hospitalCentral South University87 Xiangya RoadChangshaHunan410008China∗∗Guangtong Deng, PhD, Department of Dermatology, Xiangya Hospital, Central South University 87 Xiangya Road, Changsha, Hunan 410008, ChinaDepartment of DermatologyXiangya HospitalCentral South University87 Xiangya RoadChangshaHunan410008China
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Monday 03 November 2025
Key words : immune checkpoint inhibitors, immunotherapy, known primary, Merkel cell carcinoma, SEER, unknown primary
| Funding sources: This work was supported by the National Natural Science Foundation of China (Grant Nos. 82272849 to GD), Natural Science Fund for Outstanding Youths in Hunan Province (2023JJ20093 to GD), Huxiang Youth Talent Program (Grant Nos. 2023RC3072 to GD and 2024RC3043 to FZ) and Fundamental Research Funds for the Central Universities of Central South University (Grant Nos. 1053320241373 to ZL). |
|
| Drs Luo and Deng contributed equally to this article as corresponding author. |
|
| IRB Status: Not applicable. |
© 2025
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?